United Kingdom· GB-APID-41100311000001107
Imcivree 10mg/1ml solution for injection vials
A setmelanotide product containing setmelanotide, registered in United Kingdom by Rhythm Pharmaceuticals UK Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Setmelanotide is registered in 12 of 19 countries.
Countries holding a registration under ATC A08AA12 (setmelanotide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Setmelanotide · ATC A08AA12
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Setmelanotide
- Manufacturer
- Rhythm Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- A08AA12
- ATC class
- Setmelanotide
- Defined daily dose
- 1.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin8720682100028
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Setmelanotide in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIMCIVREERhythm Pharmaceuticals Netherlands B.V., Amsterdam
- IcelandIMCIVREERhythm Pharmaceuticals Netherlands B.V
- SwitzerlandIMCIVREE 10 mg/ml, InjektionslösungRhythm Pharmaceuticals Switzerland GmbH
- SpainIMCIVREE 10 MG/ML SOLUCION INYECTABLERhythm Pharmaceuticals Netherlands B.V.
- FinlandImcivreeRhythm Pharmaceuticals Netherlands B.V.
- FranceIMCIVREE 10 mg/ml, solution injectableRHYTHM PHARMACEUTICALS NETHERLANDS (PAYS-BAS)
- IrelandIMCIVREE 10 mg/ml solution for injectionRhythm Pharmaceuticals Netherlands B.V
- NetherlandsImcivree 10 mg/ml oplossing voor injectieRhythm Pharmaceuticals Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Imcivree
- Liechtenstein · Imcivree
- Norway · Imcivree
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/76b8e900-3163-4501-b91c-f6bd373ef7b6 GET /v1/drugs/76b8e900-3163-4501-b91c-f6bd373ef7b6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41100311000001107",
"desc": "Imcivree 10mg/1ml solution for injection vials (Rhythm Pharmaceuticals UK Ltd)",
"form": "Solution for injection",
"vpid": "41110211000001102",
"source": "dmd",
"vtm_id": "1137659002",
"strength": "10 mg",
"substance": "Setmelanotide",
"ingredient": "Setmelanotide",
"supplier_code": "39966211000001107"
}See everything about setmelanotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.